Wells Fargo & Company Prestige Consumer Healthcare Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Prestige Consumer Healthcare Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 98,270 shares of PBH stock, worth $8.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
98,270
Previous 105,216 6.6%
Holding current value
$8.12 Million
Previous $7.24 Million 2.21%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$65.26 - $75.5 $453,295 - $524,423
-6,946 Reduced 6.6%
98,270 $7.08 Million
Q2 2024

Aug 13, 2024
SELL
$62.62 - $71.76 $1.71 Million - $1.96 Million
-27,292 Reduced 20.6%
105,216 $7.24 Million
Q1 2024

May 10, 2024
SELL
$58.76 - $75.07 $472,900 - $604,163
-8,048 Reduced 5.73%
132,508 $9.61 Million
Q4 2023

Feb 09, 2024
SELL
$57.0 - $61.94 $322,734 - $350,704
-5,662 Reduced 3.87%
140,556 $8.6 Million
Q3 2023

Nov 13, 2023
SELL
$56.7 - $68.29 $10.2 Million - $12.3 Million
-179,705 Reduced 55.14%
146,218 $8.36 Million
Q2 2023

Aug 15, 2023
SELL
$56.28 - $63.76 $2.14 Million - $2.43 Million
-38,067 Reduced 10.46%
325,923 $19.4 Million
Q1 2023

May 12, 2023
SELL
$58.41 - $67.05 $375,459 - $430,997
-6,428 Reduced 1.74%
363,990 $22.8 Million
Q4 2022

Feb 13, 2023
SELL
$49.75 - $63.89 $331,036 - $425,124
-6,654 Reduced 1.76%
370,418 $23.2 Million
Q3 2022

Nov 14, 2022
SELL
$48.72 - $61.12 $1.74 Million - $2.19 Million
-35,775 Reduced 8.67%
377,072 $18.8 Million
Q2 2022

Aug 12, 2022
SELL
$52.06 - $58.9 $4.2 Million - $4.75 Million
-80,649 Reduced 16.34%
412,847 $24.3 Million
Q1 2022

May 16, 2022
BUY
$52.94 - $61.88 $151,937 - $177,595
2,870 Added 0.58%
493,496 $26.1 Million
Q4 2021

Feb 14, 2022
SELL
$55.41 - $63.3 $63.9 Million - $72.9 Million
-1,152,434 Reduced 70.14%
490,626 $29.8 Million
Q3 2021

Nov 15, 2021
SELL
$51.0 - $60.54 $1.9 Million - $2.25 Million
-37,228 Reduced 2.22%
1,643,060 $92.2 Million
Q2 2021

Aug 16, 2021
SELL
$42.92 - $53.03 $655,388 - $809,768
-15,270 Reduced 0.9%
1,680,288 $87.5 Million
Q1 2021

May 13, 2021
SELL
$36.16 - $47.63 $2.73 Million - $3.6 Million
-75,602 Reduced 4.27%
1,695,558 $74.7 Million
Q4 2020

Feb 09, 2021
SELL
$32.69 - $37.69 $5.81 Million - $6.7 Million
-177,675 Reduced 9.12%
1,771,160 $61.8 Million
Q3 2020

Nov 05, 2020
SELL
$34.54 - $40.79 $724,338 - $855,407
-20,971 Reduced 1.06%
1,948,835 $71 Million
Q2 2020

Aug 13, 2020
SELL
$36.63 - $44.07 $1.49 Million - $1.8 Million
-40,769 Reduced 2.03%
1,969,806 $74 Million
Q1 2020

May 14, 2020
BUY
$29.5 - $45.96 $59.3 Million - $92.4 Million
2,010,575 New
2,010,575 $73.7 Million

Others Institutions Holding PBH

# of Institutions
338
Shares Held
50.4M
Call Options Held
6.3K
Put Options Held
0
View Full List

About Prestige Consumer Healthcare Inc.

PBH Quotes by TradingView
  • Ticker PBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,762,600
  • Market Cap $4.11B
  • Description
  • Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's an...
More about PBH
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email